I only wish I had started sooner." "At 52, I was starting to feel constantly tired and sluggish
Fatigue is listed as a common adverse reaction (occurring in 5% of patients) in the FDA prescribing information for both Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide), and occurred more frequently than with placebo in clinical trials
But with the right approach, you can make the most of Semaglutide's potential
Pain scores improved by approximately 76% on the WOMAC scale, and more than 12% of Retatrutide-treated participants reported complete freedom from knee pain at week 68, compared to 4.2% on placebo
The most common side effects are gastrointestinal, including nausea, vomiting, diarrhoea, and abdominal discomfort, affecting more than 1 in 10 patients